Torsade de pointes occurring early during oral amiodarone treatment
- PMID: 8842793
- DOI: 10.1016/0167-5273(96)02675-7
Torsade de pointes occurring early during oral amiodarone treatment
Abstract
Amiodarone is reported to have a low incidence of proarrhythmic effects. They generally occur during chronic treatment in association with increase in amiodarone dosage, electrolyte disorders, or concomitant therapy with class IA antiarrhythmic drugs. We describe a case of amiodarone-induced torsade de pointes early after initiation of low-dose oral therapy, in absence of other predisposing factors.
Similar articles
-
Amiodarone-induced torsade de pointes in a patient with wolff-Parkinson-White syndrome.Hellenic J Cardiol. 2009 May-Jun;50(3):224-6. Hellenic J Cardiol. 2009. PMID: 19465366
-
Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.Can J Cardiol. 1997 Apr;13(4):383-6. Can J Cardiol. 1997. PMID: 9141970 Review.
-
Torsade de pointes induced by short-term oral amiodarone therapy.Europace. 2006 Dec;8(12):1051-3. doi: 10.1093/europace/eul118. Europace. 2006. PMID: 17148550
-
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.Circulation. 1992 Nov;86(5):1376-82. doi: 10.1161/01.cir.86.5.1376. Circulation. 1992. PMID: 1423949
-
Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.Pharmacotherapy. 2007 Sep;27(9):1297-305. doi: 10.1592/phco.27.9.1297. Pharmacotherapy. 2007. PMID: 17723083 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources